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Abstract: Warfarin induced skin necrosis (WISN) is a rare but important side effect of warfarin. Early diagnosis may lessen
the amount of permanent tissue damage and can prevent progression to full thickness skin necrosis. So, physi-
cians should be aware of such a complication. Screening for protein C or S or anti-thrombin deficiencies, or
presence of anti-phospholipid antibodies before beginning warfarin therapy, could be helpful to avoid high lev-
els of international normalized ratio (INR). Here, we report a 54-year-old man who presented to the emergency
department with acral and penile gangrene following prolonged use of warfarin.
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1. Introduction
Warfarin is widely used as an anticoagulant agent. War-
farin induced skin necrosis (WISN) is an uncommon but seri-
ous condition, occurring in 1:10000 patients who receive this
drug, with a female/male ratio of 1:4 (1). Skin necrosis has
been reported in 0.17% of patients affected with side effects
of warfarin (2, 3). The majority of cases present in the first
month of treatment, but late onset WISN may also occur up
to 15 years after starting the treatment (4, 5). In this report
we describe a patient who had developed late onset warfarin-
induced skin necrosis, concurrently in acral and penile area.
2. Case presentation:
The patient was a 54-years-old male presented with pe-
nis and right upper extremity pain, black discoloration and
swelling for the past two days. The patient was a known
and treated case of deep vein thrombosis from 6 years be-
fore and he was taking warfarin intermittently during this
time. He was opium addicted. The patient was a cachec-
tic man. He was completely alert (GCS =15). On ar-
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rival to the emergency department, pulse rate was 90 per
minute, respiratory rate was 18 per minute, blood pressure
was 115/70 mmHg and body temperature was 37.8 ◦C. Dis-
tal part (about one third) of his right forearm was swollen,
tender and black discolored and a bulla around the wrist
was seen. Right lower extremity was edematous. Distal
pulses of lower limbs were palpable but diminished because
of edema. Also the penis was extremely tender, swollen,
erected and dark discolored. Figure 1 shows the patient’s
lesions. His primary lab results were as follows: White
Blood Cell=6500 cells/µL, Hemoglobin=6.8 gr/dL, Hemat-
ocrit =20.3, Platelet=269000 cells/µL, Prothrombin Time (PT)
=28 s, Partial thromboplastin time (PTT)=43 s, international
normalized ratio (INR)=4.6, Blood Urea Nitrogen=10 mg/dl,
Creatinine=0.7 mg/dl, Calcium=8 mg/dl, Phosphorous=2.7
mg/dl, Total Protein=3.9 mg/dl, Albumin=1.8 mg/dl, Aspar-
tate Aminotransferase (AST)=16 U/L, Alanine Aminotrans-
ferase (ALT)=13 U/L, Lactate Dehydrogenase (LDH)=429
U/L, Creatine Phosphokinase (CPK)=83 U/L. HBs-Ag, HCV-
Ab and HIV-Ab were all reported as negative. Ultrasonog-
raphy of right hand revealed subcutaneous edema and fluid
collection. A hematoma was reported in dorsal area at the
level of first metacarpophalangeal joint. Arterial and venous
duplex of right upper extremity were normal. Also CT an-
giography of aorta to distal of right upper limb was normal
without cut off. Ultrasonography of testicles revealed right
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Figure 1: Patient’s lesions in the right upper and lower extremities as well as penis.
extra-testicular hematoma, left atrophic testis and edema of
scrotum. Duplex of both testicles were normal. Warfarin
was discontinued and correction of coagulation tests was
done by replacement of fresh frozen plasma and vitamin K.
Also cefazolin was ordered intravenously every 8 hours and
16-French foley catheter was fixed. Partial penectomy and
urethroplasty of anterior duct was done approximately two
months after admission and then amputation of right hand
above the wrist was performed. Histological findings of por-
tion of penile shaft confirmed subtotal necrosis and areas of
old and fresh hemorrhage and hematoma. The patient was
stable and discharged four days after surgery. Surgeons ad-
vised him to follow up in clinic. In our patient neither anti-
phospholipid antibodies nor low levels of protein C or S were
measured and nor heparin induced thrombocytopenia (HIT)
was considered.
3. Discussion
WISN begins as localized paresthesia with an erythematous
flush, progresses to petechial and hemorrhagic bulla and
may eventually result in full thickness necrosis (6). It usually
involves areas with more subcutaneous fat content such as
breasts, thighs, and buttocks (5, 7). Although the pathogen-
esis of the disease is still unknown, there were numerous re-
ports of inherited or functional deficiency of protein C, pro-
tein S or Factor V Leiden, antithrombin III, hyperhomocys-
teinemia or in association with HIT and anti-phospholipid
syndrome. Another theory for explaining the pathophysiol-
ogy of WISN is hypersensitivity reaction or a direct toxic ef-
fect (1, 2, 8). Obesity, premenopausal age, viral infections,
hepatic disease, and drug interactions are mentioned as pre-
disposing factors (1). The lesions must be differentiated from
necrotizing fasciitis, venous gangrene, decubitus ulcer, and
hematoma that are more common (1, 2). WISN is usually di-
agnosed clinically, based on patient’s symptoms, lesion ap-
pearance and history of recent warfarin therapy (4). Deter-
mining protein C and S levels for assessing predisposing fac-
tors and skin biopsy can aid in diagnosis. Histology typically
shows diffuse microthrombosis within dermal and subcuta-
neous capillaries, venules and deep veins, with endothelial
cell damage resulting in ischemic skin necrosis and red blood
cell extravasation (9). The lack of perivascular inflamma-
tion and arteriolar thrombosis, differentiates WISN from the
vasculitis (4, 9). Treatment includes discontinuing warfarin,
although it has not been shown to alter outcome, starting
heparin, administrating vitamin K, fresh frozen plasma (FFP)
or pure activated protein C because of its low level. Long-
term treatment includes local wound care and observation
of the wound until healing. Skin grafting, surgical debride-
ment and amputation may be necessary in severe limb gan-
grene (4, 8). WISN should be suspected in all patients who
undergo over-warfarinization, even with an initially normal
coagulation profile. Prompt diagnosis and discontinuation
of warfarin are crucial for the prognosis (1, 3). Necrosis may
be prevented by identifying high risk patients and avoiding
high dose of warfarin in high risk patients (1, 10). Several rec-
ommendations for preventing WISN have been advanced: 1)
Heparin should be continued until the INR is near the ther-
apeutic range as a result of the warfarin therapy and vitamin
K dependent clotting factors have been consumed; 2) Stan-
dard or low dose warfarin should be used instead of initial
large loading doses; 3) A clinician should be cautious when
advancing the dosage of warfarin (6).
4. Conclusion:
WISN, while rare, is an important complication following
warfarin administration. Therefore, physicians should be
aware. Screening for protein C or S or anti-thrombin defi-
ciencies, or presence of anti-phospholipid antibodies before
beginning warfarin therapy, avoiding high INR level and fi-
nally, early diagnosis may lessen the amount of permanent
tissue damage and can prevent progression to full thickness
skin necrosis.
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